Gene Therapy for the Treatment of Hemophilia B Using PINC-Formulated Plasmid Delivered to Muscle with Electroporation
Authors:
Open Access
- 1 April 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (4) , 574-583
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Repeat Transduction in the Mouse Lung by Using Adeno-Associated Virus Vectors with Different SerotypesJournal of Virology, 2000
- Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting ToxicityBlood, 1999
- Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarizationNature Medicine, 1999
- Persistent expression of canine factor IX in hemophilia B caninesGene Therapy, 1999
- Advances toward Gene Therapy for Hemophilia at the MillenniumHuman Gene Therapy, 1999
- Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorNature Medicine, 1999
- Gene Therapy for Hemophilia A and B: Patient Selection and Follow-up, Requirements for a CureThrombosis and Haemostasis, 1999
- Prophylactic Infusion Regimens in the Management of HemophiliaThrombosis and Haemostasis, 1999
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient DogsScience, 1993